Revolution to a new standard treatment of diabetic macular edema

JAMA

Volumn 311, Issue 22, 2014, Pages 2269-2270

  Jampol, Lee M ^a   Bressler, Neil M ^b   Glassman, Adam R ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JAEB CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; CORTICOSTEROID; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE; VASCULOTROPIN;

CATARACT; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DRUG EFFICACY; ENDOPHTHALMITIS; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA AGE RELATED DEGENERATION; SHORT SURVEY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL IMPAIRMENT;

ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL, HUMANIZED; DIABETIC RETINOPATHY; EVIDENCE-BASED MEDICINE; HUMANS; MACULAR EDEMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84902151808     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.2536     Document Type: Short Survey

References (9)

1. 2011 National Diabetes Fact Sheet. Centers for Disease Control and Prevention. http://www.cdc.gov/diabetes/pubs/factsheet11.htm. Accessed March 11, 2012.
2. Varma R, Bressler NM, Doan Q, et al. African Americans at highest risk of diabetic macular edema compared with non-Hispanic whites and Hispanics. Paper presented at: American Academy of Ophthalmology 2012 Annual Meeting; November 11, 2012; Chicago, IL.
3. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703-713.
4. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol. 1985;103(12):1796-1806.
5. Elman MJ, Bressler NM, Qin H, et al. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2011;118(4):609-614.
6. Elman MJ, Qin H, Aiello LP, et al. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment. Ophthalmology. 2012;119(11):2312-2318.
7. Aiello LP, Beck RW, Bressler NM, et al. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology. 2011;118(12):e5-e14.
8. Diabetic retinopathy preferred practice pattern: 2012. http://one.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp- september-2008-4th-print. Accessed February 12, 2014.
9. Bressler NM, Varma R, Doan QV, et al. Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States. JAMA Ophthalmol. 2014;132(2):168-173.